Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Public Employees Retirement Association of Colorado

Public Employees Retirement Association of Colorado cut its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,725 shares of the biotechnology company’s stock after selling 463 shares during the period. Public Employees Retirement Association of Colorado’s holdings in Axon Enterprise were worth $2,417,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Avantax Advisory Services Inc. grew its holdings in Axon Enterprise by 0.8% in the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after buying an additional 40 shares in the last quarter. Brookstone Capital Management raised its holdings in Axon Enterprise by 5.1% in the 1st quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock valued at $263,000 after buying an additional 41 shares during the period. Envestnet Portfolio Solutions Inc. lifted its position in Axon Enterprise by 1.1% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 3,997 shares of the biotechnology company’s stock valued at $1,033,000 after buying an additional 43 shares during the last quarter. UMB Bank n.a. boosted its stake in Axon Enterprise by 11.0% during the fourth quarter. UMB Bank n.a. now owns 444 shares of the biotechnology company’s stock worth $115,000 after buying an additional 44 shares during the period. Finally, Rise Advisors LLC raised its stake in shares of Axon Enterprise by 49.0% in the 1st quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock valued at $45,000 after acquiring an additional 47 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $309.00 on Tuesday. The stock has a market cap of $23.32 billion, a P/E ratio of 90.35, a P/E/G ratio of 7.00 and a beta of 0.95. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87. The stock has a 50 day moving average of $294.83 and a two-hundred day moving average of $292.75. The company has a current ratio of 2.91, a quick ratio of 2.55 and a debt-to-equity ratio of 0.37.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. The firm had revenue of $460.74 million during the quarter, compared to analysts’ expectations of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. Axon Enterprise’s quarterly revenue was up 34.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.51 EPS. On average, research analysts forecast that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have commented on AXON. Jefferies Financial Group initiated coverage on Axon Enterprise in a research note on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target on the stock. Bank of America assumed coverage on Axon Enterprise in a report on Wednesday, July 17th. They set a “buy” rating and a $380.00 target price for the company. JPMorgan Chase & Co. boosted their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research note on Thursday, April 11th. JMP Securities restated a “market outperform” rating and issued a $375.00 price objective on shares of Axon Enterprise in a report on Tuesday, May 7th. Finally, Morgan Stanley increased their target price on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $342.54.

Insider Buying and Selling

In other Axon Enterprise news, Director Julie A. Cullivan sold 993 shares of the company’s stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the completion of the sale, the director now directly owns 4,553 shares of the company’s stock, valued at approximately $1,282,671.16. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director Julie A. Cullivan sold 478 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total value of $136,727.12. Following the completion of the sale, the director now owns 5,546 shares in the company, valued at $1,586,377.84. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Julie A. Cullivan sold 993 shares of Axon Enterprise stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $281.72, for a total value of $279,747.96. Following the completion of the sale, the director now directly owns 4,553 shares in the company, valued at approximately $1,282,671.16. The disclosure for this sale can be found here. Insiders have sold a total of 89,447 shares of company stock valued at $27,684,677 over the last quarter. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.